Thank you for participating in the industry’s first-ever survey of quality control management practice in clinical next-generation sequencing. By focusing on how clinical NGS labs determine QC stops; the impact of QC stops on reporting results, lab productivity, and reimbursement; and the use of tools such as reference materials and data management solutions, we will collectively gain greater insight into the QC habits and best practices of the clinical NGS community worldwide.

This five-minute survey is completely anonymous, and one participant will receive a $500 Amazon gift card.

Make sure to join us and a panel of clinical genomics experts who will report and discuss the results of this survey at a September 17th webinar on practical approaches to NGS QC management programs. Click here for more information and to register.

                                                                                                                     


Do you currently perform next-generation sequencing for clinical testing?

Question Title

* Do you currently perform next-generation sequencing for clinical testing?

T